Malaria vaccine will be made in India.
Malaria vaccine will be made in India.
Malaria R21/Matrix-M Vaccine: A new vaccine for Malaria is about to come, which is being called a world changer. The name of this vaccine is R21/Matrix-M. It is being said that this will be the first such vaccine in the world, which will meet the effective criteria of the World Health Organization up to 75 percent. Explain that this vaccine developed by Oxford University will be made in India. The special thing is that a deal has also been done in Oxford and Serum Institute of India regarding this vaccine. On one hand the World Health Organization is considering approving this vaccine, while on the other hand Ghana has also approved this vaccine. The Food and Drugs Authority of Ghana has approved this vaccine for use in children aged 5-36 months. Let us tell you that children of this age group in African regions are more at risk of malaria.
New Malaria Vaccine R21/Matrix-M
Regarding this malaria vaccine, Professor Adrian Hill from Oxford said that this vaccine has been developed after 30 years of research. He said, after manufacturing in India, the vaccine will be delivered to all the needy countries. He further informed that our partnership with Serum Institute of India for the Covid-19 vaccine was very successful. This is the reason why a deal has also been done for the malaria vaccine. Explain that R21/Matrix-M is a one-dose vaccine for malaria, which will be made on a large scale at a nominal cost. In this way, millions of doses of vaccine can be supplied to African countries battling malaria.
Know how effective is the malaria vaccine
Professor Adrian Hill has published his findings from the Phase IIB trial of the vaccine in a journal, according to which his vaccine has demonstrated a high-level efficacy of 77 per cent over a 12-month follow-up. They reported vaccine efficacy of 77 percent in the high-dose support group and 71 percent in the low-dose support group. According to this, no serious side effects related to the 12-month follow-up vaccine have yet been seen. Tell that in the last few decades, more than 100 malaria vaccines were trained. None of these vaccines fell short of the WHO’s target of an anti-malarial vaccine. Now this new vaccine has been described as 75 percent true on WHO’s effective parameters.
Adar Poonawala said this about the vaccine
Let us tell you that the R21 / Matrix-M vaccine has initially been clinically tested in UK, Thailand and many African countries. This includes Phase III trials in Burkina Faso, Kenya, Mali and Tanzania. Apart from this, ‘Serum Institute of India’ said about the new R21 vaccine of malaria that it has the capacity to make more than 200 million doses annually. Serum Institute CEO Adar Poonawalla said the licensing of the vaccine by the Ghanaian authorities would mark an important milestone in the fight against malaria.
